These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

212 related articles for article (PubMed ID: 24858727)

  • 41. Psychotropic prescribing in people with intellectual disability and challenging behaviour.
    Sheehan R; Strydom A; Morant N; Pappa E; Hassiotis A
    BMJ; 2017 Aug; 358():j3896. PubMed ID: 28821479
    [No Abstract]   [Full Text] [Related]  

  • 42. A critical appraisal of recent drug research in mental retardation: the Coldwater studies.
    Aman MG; Singh NN
    J Ment Defic Res; 1986 Sep; 30 ( Pt 3)():203-16. PubMed ID: 2878082
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Is higher psychotropic medication burden associated with involuntary treatment under the Mental Health Act? A four-year Australian cohort study.
    Wheeler AJ; Hu J; Profitt C; McMillan SS; Theodoros T
    BMC Psychiatry; 2020 Jun; 20(1):294. PubMed ID: 32527250
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Current status of the Matson Evaluation of Drug Side Effects (MEDS).
    Matson JL; Cervantes PE
    Res Dev Disabil; 2013 May; 34(5):1849-53. PubMed ID: 23528442
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Central nervous system medication use in older adults with intellectual disability: Results from the successful ageing in intellectual disability study.
    Chitty KM; Evans E; Torr JJ; Iacono T; Brodaty H; Sachdev P; Trollor JN
    Aust N Z J Psychiatry; 2016 Apr; 50(4):352-62. PubMed ID: 26019276
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Improving knowledge of psychotropic prescribing in people with Intellectual Disability in primary care.
    Shankar R; Wilcock M
    PLoS One; 2018; 13(9):e0204178. PubMed ID: 30216381
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Problem behaviours and psychotropic medication use in intellectual disability: a multinational cross-sectional survey.
    Perry BI; Cooray SE; Mendis J; Purandare K; Wijeratne A; Manjubhashini S; Dasari M; Esan F; Gunaratna I; Naseem RA; Hoare S; Chester V; Roy A; Devapriam J; Alexander R; Kwok HF
    J Intellect Disabil Res; 2018 Feb; 62(2):140-149. PubMed ID: 29349928
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Use of psychotropic drugs in children, adolescents and subjects with intellectual disability: a review].
    Lazzeretti L; Pracucci C; Benni L; Godini L; Talamba GA; Faravelli C
    Riv Psichiatr; 2011; 46(1):1-17. PubMed ID: 21446107
    [TBL] [Abstract][Full Text] [Related]  

  • 49. National trends in psychotropic medication polypharmacy in office-based psychiatry.
    Mojtabai R; Olfson M
    Arch Gen Psychiatry; 2010 Jan; 67(1):26-36. PubMed ID: 20048220
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Determinants of psychotropic medication in adults with mild or moderate intellectual disabilities].
    Schützwohl M; Voss E; Stiawa M; Salize HJ; Puschner B; Koch A
    Nervenarzt; 2017 Nov; 88(11):1273-1280. PubMed ID: 27638741
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Antipsychotic and antidepressant prescribing for 704 297 children and young people with and without intellectual disabilities: record linkage study.
    Henderson A; Kinnear D; Fleming M; Stanley B; Greenlaw N; Young-Southward G; Pell JP; Cooper SA
    Br J Psychiatry; 2021 Jan; 218(1):58-62. PubMed ID: 33541472
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Rating scales to measure adverse effects of medications in people with intellectual disability: a scoping review.
    Kelly N; Kilmartin A; Lannon K; Lee C; McLoughlin R; Mulvanny L; Mohamed O; Treacy M; Rossi K; O'Connell J
    Eur J Clin Pharmacol; 2022 Nov; 78(11):1711-1725. PubMed ID: 36042024
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Factors associated with polypharmacy and excessive polypharmacy in older people with intellectual disability differ from the general population: a cross-sectional observational nationwide study.
    O'Dwyer M; Peklar J; McCallion P; McCarron M; Henman MC
    BMJ Open; 2016 Apr; 6(4):e010505. PubMed ID: 27044582
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Psychotropic drug and polypharmacy use among adolescents and young adults: findings from the Finnish 1981 Nationwide Birth Cohort Study.
    Gyllenberg D; Sourander A
    Nord J Psychiatry; 2012 Oct; 66(5):336-42. PubMed ID: 22212103
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Use of psychotropic medication in people with a learning disability.
    Jenkins R
    Br J Nurs; 2000 Jul 13-26; 9(13):844-50. PubMed ID: 11261057
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Psychotropic medication use in adults with intellectual disability in Queensland, Australia, from 1999 to 2015: a cohort study.
    Song M; Ware R; Doan TN; Harley D
    J Intellect Disabil Res; 2020 Jan; 64(1):45-56. PubMed ID: 31478300
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Unnecessary psychotropic drug prescription in primary care for people with intellectual disability.
    Trollor J; Salomon C
    Evid Based Ment Health; 2016 May; 19(2):62. PubMed ID: 27075445
    [No Abstract]   [Full Text] [Related]  

  • 58. Psychotropic and anticonvulsant drug use by mentally retarded adults across community residential and vocational placements.
    Martin JE; Agran M
    Appl Res Ment Retard; 1985; 6(1):33-49. PubMed ID: 2859836
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Trends in the use of psychotropic drugs in people with intellectual disability in Taiwan: a nationwide outpatient service study, 1997-2007.
    Hsu SW; Chiang PH; Chang YC; Lin JD; Tung HJ; Chen CY
    Res Dev Disabil; 2014 Feb; 35(2):364-72. PubMed ID: 24333807
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Trends in the residential (inpatient) treatment of individuals with a dual diagnosis.
    Spreat S; Behar D
    J Consult Clin Psychol; 1994 Feb; 62(1):43-8. PubMed ID: 7913478
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.